Method and composition for reducing blood glucose levels
AssigneeNippon Shinyaku Co., Ltd.
InventorsKatsuya Ohata, Hiroshi Enomoto, Yoshiaki Yoshikuni, Tatsuhiko Kono, Masahiro Yagi
Life of this patent
Estimating the term…
Abstract
2-Hydroxymethyl-3,4,5-trihydroxypiperidine possesses antidiabetic and lipid biosynthesis inhibitory properties. The use of the compound for such indications and pharmaceutical compositions adapted to this use are described.
Claims4
The method of reducing blood glucose levels and inhibiting lipid biosynthesis in humans and other animals which comprises orally, rectally or parentally administering thereto an effective amount of 2-hydroxymethyl-3,4,5-trihydroxypiperidine.
A pharmaceutical composition for use in reducing blood glucose levels and inhibiting lipid biosynthesis which comprises an effective amount of 2-hydroxymethyl-3,4,5-trihydroxypiperidine and a nontoxic carrier.
An animal feed comprising an amount of 2-hydroxymethyl-3,4,5-trihydroxypiperidine effective to inhibit lipid biosynthesis in combination with an edible carrier.
Dependencies are inferred from the claim text.